Copyright © Inderes 2011 - present. All rights reserved.
Log in to receive notifications.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Neola Medical secures U.S. trademark of Neola® logo ahead of market launch

Neola Medical

Neola Medical AB announces that the company’s Neola® logotype featuring a lung symbol has been registered as trademark in the U.S. Trademark protection is a cornerstone of Neola Medical’s commercialization strategy, reinforcing the company’s position in the neonatal market and further enhancing its competitiveness ahead of market launch in the U.S. of the company’s medical device for continuous lung monitoring of preterm born babies.

“Securing trademark registration of the Neola® logotype in the U.S. is a key component of our market launch strategy. This trademark not only safeguards our intellectual property in our most important market, but also elevates the Neola® brand as a symbol of trust and innovation in neonatal care. Our brand represents quality, safety, and an aim to transform the standard of care in neonatal intensive care units around the world.”, says CEO Hanna Sjöström

Neola Medical introduced its new company name and branding platform in 2022, to align with the company’s positioning as a leading MedTech provider in neonatal intensive care. The Neola® logo, featuring a symbol that combines the image of lungs with the letter "N," was designed to reflect this focus. Trademark registration for the Neola® logo has already been secured in Europe and China.

For further information, contact:
Hanna Sjöström, CEO
e-mail: hanna.sjostrom@neolamedical.com

About Neola Medical
Neola Medical AB (publ) develops revolutionizing medical technology device for non-invasive continuous lung monitoring and real-time alerts of life-threatening lung complications of preterm born infants. Immediate detection of complications provides the possibility of early treatment, improved health care and healthier lives for preterm born infants. The patented cutting-edge technology is developed at Lund University in Sweden and based on a spectroscopic method that measures lung volume changes and oxygen gas concentration. Neola Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care. The company was founded in 2016 and is listed on NASDAQ First North Growth Market (ticker: NEOLA). Read more at www.neolamedical.com. The company’s Certified Adviser is FNCA Sweden AB.

Attachments
Neola Medical secures U.S. trademark of Neola® logo ahead of market launch

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team